Episodic antiretroviral therapy increases hiv transmission risk compared with continuous therapy: Results of a randomized controlled trial

Journal of Acquired Immune Deficiency Syndromes

Volumn 49, Issue 2, 2008, Pages 142-150

  Burman, William ^a,b   Grund, Birgit ^c   Neuhaus, Jacqueline ^c   Douglas Jr , John ^d   Friedland, Gerald ^e   Telzak, Edward ^f   Colebunders, Robert ^g   Paton, Nicholas ^h   Fisher, Martin ⁱ   Rietmeijer, Cornells ^a,b  

^a DENVER PUBLIC HEALTH   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF ANTWERP   (Belgium)

^h MEDICAL RESEARCH COUNCIL   (United Kingdom)

ⁱ ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

Author keywords

Antiretroviral therapy; High risk behavior; HIV transmission risk; Randomized trial

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA; ANTIVIRUS AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; CHLAMYDIA; CLINICAL TRIAL; COMPARATIVE STUDY; CONDOM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABUSE; DRUG INTERMITTENT THERAPY; FEMALE; GENE AMPLIFICATION; GENOTYPE; GONORRHEA; HIGH RISK BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEX RATIO; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; VIRUS RESISTANCE; VIRUS TRANSMISSION; BLOOD; DISEASE TRANSMISSION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; RISK ASSESSMENT; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK-TAKING; RNA, VIRAL; VIRAL LOAD;

EID: 55249084385     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318183a9ad     Document Type: Article

References (25)

1. Lori F, Lisziewicz J. Structured treatment interruptions for the management of HIV infection. JAMA. 2001;286:2981-2987.
2. Hogg RS. Havlir D, Miller V, el al. To slop or not to stop: that is the question, but what is the answer? AIDS. 2002;16:787-789.
3. Mofcnson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl .1 Med. 1999;341:385-393.
4. Quinn TC, Wawcr MH, Scwankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. ,N Engl J Med. 2000;342:921-929.
5. Tovanabutra S, Robison V, Wongtrakul J, et al. Male viral load and heterosexual transmission of HIV-I subtype E in northern Thailand. J Acquir Immune Defic Syndr. 2002;29:275-283.
6. Teicher E, Casagrande T, Vittecoq D. Enhanced risk of HIV sexual transmission during structured treatment interruption. Sex Transm Inject. 2003;79:74.
7. Chen SY, Gibson S, Katz MH, et al. Continuing increases in sexual risk behavior and sexually transmitted diseases among men who have sex with men: San Francisco, Calif, 1999-2001, USA. Am J Public Health. 2002; 92:1387-1388.
8. Dodds JP, Mereey DE, Parry JV, et al. Increasing risk behaviour and high levels of undiagnosed HIV infection in a community sample of homosexual men. Sex Transm Infect. 2004;80:236-240.
9. Nicoll A. Hamers FF. Are trends in HIV, gonorrhoea, and syphilis worsening in western Europe? BMJ. 2002;324:1324-1327.
10. Heffelfinger .ID, Swint EB, Berman SM, et al. Trends in primary and secondary syphilis among men who have sex with men in the United States. Am J Public Health. 2007;97:1076-1083.
11. Katz MH, Schwarcz SK, Kellogg TA, et al. Impact of highly aclive antiretroviral treatment on HIV seroincidence among men who have sex with men: San Francisco. Am J Public Health. 2002;92:388-394.
12. The SMART Study Group. CD 4+ count-guided interruption of antiretroviral treatment. N Engl J Med. 2006;355:2283-2296.
13. Rietmeijcr CA, Lansky A, Anderson JE, et al. Developing standards in behavioral surveillance for HIVSTD prevention. AIDS Educ Prev. 2001; 13:268-278.
14. Johnson VA. Brun-Vezinct F, Clotet B, et al. Update of the drug resistance mutations in HIV-1: Fall 2006. Top HIV Med. 2006;14:125-130.
15. Flaks RC. Burman WJ, Gourley PJ, et al. HIV Iransmission risk behavior and its relation to antiretroviral treatment adherence. Sex Transm Dis. 2003;30:399-404.
16. Wenger NS. Kusseling FS. Beck K, et al. Sexual behavior of individuals infected with the human immunodeficiency virus. The need for intervention. Arch Intern Med. 1994;154:1849-1854.
17. Erbelding EJ, Stanton D. Quinn TC, el al. Behavioral and biologic evidence of persistent high-risk behavior in an HlV primary care population. AIDS. 2000;14:297-301.
18. Kozal MJ, Amico KR, Chiarella J. et al. Antiretroviral resistance and highrisk transmission behavior among HIV-positive patients in clinical care. AIDS. 2004;18:2185-2189.
19. Crepaz N, Hart TA. Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA. 2004;292:224-236.
20. Desquilbet L, Deveau C, Goujard C, et al. Increase in at-risk sexual behaviour among HIV-1-infected patients followed in the French PRIMO cohort. AIDS. 2002;16:2329-2333.
21. Glass TR, Young J, Vernazza PL, et al. Is unsafe sexual behaviour increasing among HIV-infected individuals? AIDS. 2004:18:1707-1714.
22. Bouhnik AD, Moatti JP, Vlahov D, et al. Highly active antiretroviral treatment does not increase sexual risk behaviour among French HIV infected injecting drug users. J Epidemiol Community Health. 2002;56: 349-353.
23. Wilson TE, Gore ME, Greenblatt R, et al. Changes in sexual behavior among HIV-infected women after initiation of HAART Am J Public Health. 2004;94:1141-1146.
24. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2004. Centers for Disease Control and Prevention, Atlanta, GA; 2005:1-46.
25. Kent CK, Chaw JK, Wong W. et al. Prevalence of rectal, urethral, and pharyngeal chlamydia and gonorrhea detected in 2 clinical settings among men who have sex with men: San Francisco, California, 2003. Clin Infect Dis. 2005;41:67-74.